Entity

Time filter

Source Type

Cambridge, MA, United States

VBI Vaccines | Entity website

Vaccines and biologics vary greatly in their ability to remain viable during handling,storage, and administration. The stability of a particular vaccine formulation depends on many factors including the type of antigen (active ingredient) and the presence of other vaccine components such as adjuvants, stabilizers, and preservatives ...


VBI Vaccines | Entity website

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology ...


VBI Vaccines | Entity website

SUBSCRIBE TO RECEIVE NEWS AND INSIGHTS BY EMAIL


VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI) has received a No Objection Letter from Health Canada, providing clearance to begin enrolling Canadian participants in a Phase I clinical study to evaluate VBIs preventative cytomegalovirus (CMV) vaccine candidate in humans ...


VBI Vaccines | Entity website

SUBSCRIBE TO RECEIVE NEWS AND INSIGHTS BY EMAIL

Discover hidden collaborations